Roche
RO.SW
#45
Rank
NZ$571.64 B
Marketcap
NZ$718.50
Share price
0.97%
Change (1 day)
24.83%
Change (1 year)

EPS for Roche (RO.SW)

EPS in 2025: NZ$35.02

According to Roche's latest financial reports the company's current EPS (TTM) is NZ$35.02. In 2025 the company made an earnings per share (EPS) of NZ$35.02 an increase over its 2024 EPS that were of NZ$19.71.

EPS history for Roche from 1998 to 2025

Annual EPS

Year EPS Change
2025NZ$35.0277.67%
2024NZ$19.71-32.84%
2023NZ$29.351.95%
2022NZ$28.79-6.29%
2021NZ$30.72-5.53%
2020NZ$32.5216.56%
2019NZ$27.9030.3%
2018NZ$21.4120.22%
2017NZ$17.81-5.81%
2016NZ$18.914.62%
2015NZ$18.07-5.13%
2014NZ$19.05-25.05%
2013NZ$25.4221.73%
2012NZ$20.883.82%
2011NZ$20.118.16%
2010NZ$18.5923.72%
2009NZ$15.03-12.31%
2008NZ$17.14-0.34%
2007NZ$17.2032.13%
2006NZ$13.0242.56%
2005NZ$9.13-22.7%
2004NZ$11.81132.85%
2003NZ$5.07-148.05%
2002NZ-$10.55-209.09%
2001NZ$9.68-57.03%
2000NZ$22.5253.29%
1999NZ$14.6931.24%
1998NZ$11.19

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$14.97-57.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$12.03-65.65%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$2.24-93.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
NZ$6.18-82.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$24.81-29.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$4.39-87.48%๐Ÿ‡ซ๐Ÿ‡ท France
Becton Dickinson
BDX
NZ$9.36-73.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$6.10-82.59%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$6.66-80.98%๐Ÿ‡ฌ๐Ÿ‡ง UK